Combined radiotherapy and anti-CTLA-4 antibodies for brain metastases of malignant melanom
Laufzeit: 01.01.2015 - 31.12.2017
Laufzeit: 01.01.2015 - 31.12.2017
Retrospective analyses of outcome data of patients with brain metastases of malignant melanomastreated with combined radiotherapy and anti-CTLA-4 blocking antibodies compared with historic controls which have been treated with radiotherapy of brain lesions alone.